NDRA · ENDRA Life Sciences Inc. · Investor Relations
$6.06
+0.18 (+3.06%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, management believes that without the closing of the Merger, given our current cash position and forecasted negative cash flows from operating activities over the next twelve months, there is substantial doubt about our ability to continue as a going concern after the date that is one year from the date that these financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$9.06M
Shares
1.50M
Volume · Oct 2
39.79K
Avg daily vol (3M)
36.4K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2024-08-22 | Second Quarter 2024 Financial Results | Results publication |
| 2023-12-07 | The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference | Conference |
| 2022-11-14 | Third Quarter 2022 Financial Results | Results publication |
| 2021-11-15 | ENDRA Life Science 3Q21 Financial Results | Results publication |
| 2020-11-16 | ENDRA Life Sciences Inc. Third Quarter 2020 Earnings Call | Earnings call |
| 2018-12-05 | 11th Annual LD Micro Main Event | Event |
| 2017-12-06 | LD Micro Main Event | Event |
Source: http://investors.endrainc.com/